Wyeth is pleased to offer the Factor Resource Program to affirm our continued support of the hemophilia community. The program was developed to allow hemophilia patients to get the factor they need—ReFacto for hemophilia A and BeneFIX for hemophilia B. Three distinct services make up the program—the Insurance-Coverage Program, the Patient Assistance Program, and the Reimbursement-Information Line—and are designed to work together. That means we've pretty much got you covered.

The Factor Resource Program includes

• Insurance-Coverage Program
  Provides up to 12 months of free hemophilia factor product to program participants experiencing a lapse in insurance coverage. In addition, participants will receive assistance tracking their insurance cap and identifying alternative sources of insurance.
• Patient Assistance Program
  Provides a supply of Wyeth hemophilia product, at no cost, to hemophilia patients who are without insurance and who meet other eligibility criteria.
• Reimbursement-Information Line
  If you should have questions about reimbursement for your Wyeth hemophilia product, make sure you take advantage of the Wyeth Reimbursement-Information Line.

Please note: All personal data for these programs are collected by a third party; Wyeth does not have access to that information. To learn more, please read our Privacy Policy.

Program Terms and Conditions

Indication
BeneFIX is indicated for the control and prevention of hemorrhagic episodes in patients with hemophilia B (congenital factor IX deficiency or Christmas disease), including control and prevention of bleeding in surgical settings. BeneFIX is not indicated for the treatment of other factor deficiencies (eg, factors II, VII, VIII and X) nor the treatment of hemophilia A patients with inhibitors to factor VIII, nor the reversal of coumarin-induced anticoagulation, nor the treatment of bleeding due to low levels of liver-dependent coagulation factors.

Important Safety Information

	•	As with the intravenous administration of any protein product, common adverse reactions may include headache, fever, chills, flushing, nausea, vomiting, or tiredness.
	•	BeneFIX may be contraindicated in patients with a known history of hypersensitivity to hamster protein.
	•	Allergic-type hypersensitivity reactions, including anaphylaxis, have been reported for all factor IX products. Patients should be informed of the early symptoms and signs of hypersensitivity reactions. Patients should discontinue use of the product and contact their health care provider immediately and/or seek emergency care if any hypersensitivity reactions occur.

Please see BeneFIX Prescribing Information

Indication
ReFacto is indicated for the control and prevention of hemorrhagic episodes and for surgical prophylaxis and for short-term routine prophylaxis to reduce the frequency of spontaneous bleeding episodes in patients with hemophilia A. The effect of regular routine prophylaxis on long-term morbidity and mortality is unknown.

Important Safety Information

	•	As with the intravenous administration of any protein product, adverse reactions may include headache, fever, chills, flushing, nausea, vomiting, tiredness, or symptoms of allergic reactions.
	•	The remote possibility exists for hypersensitivity to non-human mammalian proteins. Known hypersensitivity to mouse or hamster proteins may be a contraindication to the use of ReFacto.
	•	Allergic reactions such as hives, itching, difficulty breathing, rapid heart rate, light-headedness and anaphylaxis have been reported for all factor VIII products. Patients should discontinue use of the product and contact their health care provider immediately and/or seek emergency care if any of these symptoms occur.

Please see ReFacto Prescribing Information

The health information contained herein is provided for educational purposes only and is not meant to replace personal discussions between health care providers and patients. All decisions about patient care must be made with a health care provider who can assess the special needs of each individual patient.